Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17961972 | 0.77 | NAALAD2 (0.47) | NAALAD2EPHX1ALDH1A1THRBPKM | |
| SCHEMBL2997885 | 0.74 | NAALAD2 (0.50) | NAALAD2ALDH1A1THRBPKM | |
| SCHEMBL5607969 | 0.73 | NAALAD2 (0.47) | NAALAD2EPHX1ALDH1A1THRBPKM | |
| SCHEMBL13544391 | 0.73 | NAALAD2 (0.47) | NAALAD2EPHX1ALDH1A1THRBPKM | |
| SCHEMBL30410707 | 0.72 | NAALAD2 (0.47) | NAALAD2ALDH1A1THRBPKM | |
| SCHEMBL14879626 | 0.71 | NAALAD2 (0.45) | NAALAD2EPHX1ALDH1A1THRBPKM | |
| SCHEMBL25446061 | 0.71 | NAALAD2 (0.45) | NAALAD2EPHX1ALDH1A1THRBPKM | |
| SCHEMBL9978303 | 0.69 | NAALAD2 (0.44) | NAALAD2EPHX1ALDH1A1 | |
| SCHEMBL14331628 | 0.69 | NAALAD2 (1.00) | NAALAD2ALDH1A1THRB | |
| SCHEMBL8995750 | 0.68 | FPR2 (0.50) | NAALAD2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026277-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE | MICROX CO., LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026277-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE | RELA, CSNK2A1, CSNK1G1 | NAALAD2 1556/4885EPHX1 3966/4885ALDH1A1 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.